Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7483)
All Articles published online
|
Publishing Process of This Article
|
Nov 24, 2020 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mielgo-Rubio X, Rojo F, Mezquita-Pérez L, Casas F, Wals A, Juan M, Aguado C, Garde-Noguera J, Vicente D, Couñago F. Deep diving in the PACIFIC: Practical issues in stage III non-small cell lung cancer to avoid shipwreck. World J Clin Oncol 2020; 11(11): 898-917 [PMID: 33312885 DOI: 10.5306/wjco.v11.i11.898] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i11/898.htm |
| Number | Citing Articles |
| 1 |
Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim. Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab after Concurrent Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer: Insights from Real-World Data. Cancer Research and Treatment 2024; 56(3): 785 doi: 10.4143/crt.2023.1014
|
| 2 |
Kim M. Kraus, Julius C. Fischer, Kai J. Borm, Marco M. E. Vogel, Steffi. U. Pigorsch, Michal Devečka, Stephanie E. Combs. Evaluation of practical experiences of German speaking radiation oncologists in combining radiation therapy with checkpoint blockade. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86863-2
|
| 3 |
Martin Svatoň, Daniel Krejčí. Treatment options for non-small cell lung stage III cancer. Onkologie 2021; 15(6): 272 doi: 10.36290/xon.2021.051
|
| 4 |
Meghan J. Mooradian, Ling Cai, Alice Wang, Yao Qiao, Pratibha Chander, Ryan M. Whitaker. Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non–Small Cell Lung Cancer. JAMA Network Open 2024; 7(4): e247542 doi: 10.1001/jamanetworkopen.2024.7542
|
| 5 |
Samuel A. Kareff, Sunwoo Han, Benjamin Haaland, Chinmay J. Jani, Rhea Kohli, Pedro Nazareth Aguiar, Yiqing Huang, Ross A. Soo, Ángel Rodríguez-Perez, Jesús García-Foncillas, Manuel Dómine, Gilberto de Lima Lopes. International Cost-Effectiveness Analysis of Durvalumab in Stage III Non–Small Cell Lung Cancer. JAMA Network Open 2024; 7(5): e2413938 doi: 10.1001/jamanetworkopen.2024.13938
|
| 6 |
Abed Agbarya, Walid Shalata, Alfredo Addeo, Andriani Charpidou, Kristof Cuppens, Odd Terje Brustugun, Mirjana Rajer, Marco Jakopovic, Mihai V. Marinca, Adam Pluzanski, Jeroen Hiltermann, António Araújo. Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment. Journal of Clinical Medicine 2022; 11(6): 1738 doi: 10.3390/jcm11061738
|
| 7 |
Thiago Bueno de Oliveira, Debora Maloni Nasti Fontes, Tatiane Caldas Montella, Jairo Lewgoy, Carolina Dutra, Thais Manfrinato Miola. The Best Supportive Care in Stage III Non-Small-Cell Lung Cancer. Current Oncology 2023; 31(1): 183 doi: 10.3390/curroncol31010012
|